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Abstract 
AIMS: 
Pre-procedural identification of patients with atrial fibrillation (AF) who will benefit most from 
pulmonary vein isolation remains challenging. The HATCH score [Hypertension x1 + Age≥75 x1 
+ Thrombo-embolic event x2, COPD x1, Heart failure x2] has been associated with progression 
of AF and recently with adverse outcomes after catheter ablation. However, data regarding the 
HATCH score are limited. This study aimed to evaluate the performance of a modified HATCH 
scoring system, including pre-procedural obstructive sleep apnea as an additional risk element, 
compared to the CHADS risk score as a predictor of AF recurrence after an index pulmonary 
vein isolation procedure for AF.  
METHODS AND RESULTS: 
Seventy eight patients (48 men, mean age 60 ± 1.1 years) with paroxysmal or persistent AF 
underwent an index pulmonary vein isolation procedure between 2010 and 2014 using either 
radiofrequency (n=64) or cryoballoon (n = 14). Over a 6-month follow-up period, 35 patients had 
recurrence (44.9%) when monitored using Holter monitoring and in-office ECGs. The modified 
HATCH score was associated on univariate testing with AF recurrence. In multivariate logistic 
regression analyses including factors known to be associated with AF recurrence, the modified 
HATCH score (p: 0.03) was independently associated with AF recurrence and showed superior 
test characteristics using ROC curve analysis (C statistic = 0.64 for modified HATCH vs. 0.55 for 
CHADS2). The difference between the modified HATCH and the CHADS2 scores in predicting 
recurrence was not statistically significant (p = 0.8). 
CONCLUSIONS: 
AF recurred in 44% of patients over a 6-month follow-up. A modified HATCH including OSA 
successfully identified individuals at risk for 6-month recurrence. Further research is needed 
including larger cohorts of patients undergoing ablation and followed for more extended periods 
to further validate the performance of the modified HATCH score. 
